BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3652528)

  • 1. Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.
    Lobatto S; Daha MR; Voetman AA; Evers-Schouten JH; Van Es AA; Pauwels EK; Van Es LA
    Clin Exp Immunol; 1987 Jul; 69(1):133-41. PubMed ID: 3652528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal clearance of soluble aggregates of human immunoglobulin G in patients with systemic lupus erythematosus.
    Lobatto S; Daha MR; Breedveld FC; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; Van Es LA
    Clin Exp Immunol; 1988 Apr; 72(1):55-9. PubMed ID: 3396221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of soluble 123I-labelled aggregates of human immunoglobulin G in humans; the effect of splenectomy.
    Halma C; Daha MR; van Furth R; Camps JA; Evers-Schouten JH; Pauwels EK; Lobatto S; Van Es LA
    Clin Exp Immunol; 1989 Jul; 77(1):62-6. PubMed ID: 2788541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement enhances the elimination of soluble aggregates of IgG by rat liver endothelial cells in vivo.
    Bogers WM; van Rooijen N; Janssen DJ; van Es LA; Daha MR
    Eur J Immunol; 1993 Feb; 23(2):433-8. PubMed ID: 8436178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in clearance kinetics of particulate immune complexes and soluble aggregates of IgG in vivo.
    Veerhuis R; Krol MC; van Es LA; Daha MR
    Clin Immunol Immunopathol; 1986 Dec; 41(3):379-91. PubMed ID: 3780052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study of in vivo immune complex formation and clearance in man.
    Davies KA; Hird V; Stewart S; Sivolapenko GB; Jose P; Epenetos AA; Walport MJ
    J Immunol; 1990 Jun; 144(12):4613-20. PubMed ID: 2141040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of monomeric immunoglobulin G (IgG) on the clearance of soluble aggregates of IgG in man.
    Halma C; Daha MR; van der Meer JW; Cohen A; van Furth R; Breedveld FC; Evers-Schouten JH; Pauwels EK; van Es LA
    J Clin Lab Immunol; 1991 May; 35(1):9-15. PubMed ID: 1668290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished clearance of soluble aggregates of human immunoglobulin G in patients with rheumatoid arthritis.
    Lobatto S; Daha MR; Westedt ML; Pauwels EK; Evers-Schouten JH; Voetman AA; Cats A; van Es LA
    Scand J Rheumatol; 1989; 18(2):89-96. PubMed ID: 2734596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies in cobra venom factor treated rats of antibody coated erythrocyte clearance by the spleen: differential influence of red blood cell antigen number on the inhibitory effects of immune complexes on Fc dependent clearance.
    Yousaf N; Howard JC; Williams BD
    Clin Exp Immunol; 1986 Dec; 66(3):654-60. PubMed ID: 3568453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
    Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
    Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear phagocyte system Fc-receptor function in patients with seropositive rheumatoid arthritis.
    Lobatto S; Breedveld FC; Camps JA; Pauwels EK; Westedt ML; Daha MR; van Es LA
    Clin Exp Immunol; 1987 Mar; 67(3):461-6. PubMed ID: 3111762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo degradation of rat C1q induced by intravenous injection of soluble IgG aggregates.
    Veerhuis R; van Es LA; Daha MR
    Immunology; 1985 Apr; 54(4):801-10. PubMed ID: 3872261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the endocytosis of immune complexes.
    van Es LA; Daha MR
    Adv Nephrol Necker Hosp; 1984; 13():341-67. PubMed ID: 6236677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective splenic reticuloendothelial function in idiopathic membranous nephropathy.
    McGinley E; Martin W; Henderson N; Boulton-Jones JM
    Clin Exp Immunol; 1984 May; 56(2):295-301. PubMed ID: 6587955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement enhances the clearance of large-sized soluble IgA aggregates in rats.
    Bogers WM; Stad RK; Janssen DJ; Rits M; Bazin H; Van Es LA; Daha MR
    Eur J Immunol; 1991 May; 21(5):1093-9. PubMed ID: 2037008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kupffer cell depletion in vivo results in preferential elimination of IgG aggregates and immune complexes via specific Fc receptors on rat liver endothelial cells.
    Bogers WM; Stad RK; Janssen DJ; van Rooijen N; van Es LA; Daha MR
    Clin Exp Immunol; 1991 Nov; 86(2):328-33. PubMed ID: 1934600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptors for IgG and complement in human spleen lymphoid cells. Preferential binding of particulate immune complexes through complement receptors.
    Scornik JC; Drewinko B
    J Immunol; 1975 Nov; 115(5):1223-6. PubMed ID: 1176774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of Kupffer cell Fc receptor function in vivo following injury.
    Loegering DJ; Blumenstock FA; Cuddy BG
    Proc Soc Exp Biol Med; 1989 Dec; 192(3):255-60. PubMed ID: 2602390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.